NYSE:GMED

Globus Medical Stock Insider Trading

etoro logo Buy GMED
*Your capital is at risk
$80.86
-1.66 (-2.01%)
At Close: Jun 10, 2026

Globus Medical Stock Insider Power

Based on the 100 latest insides trades, we have calculated the insider power to be negative at -8.10. In total, the insiders bought 1.92M and sold 184.24K GMED shares in the last 100 trades. The insider score can be negative despite buy/sell ratio being positive. The score focuses on the quality of the trades.

Insider Power

(Last 100 transactions)
-8.10
Buy 1.92M shares
Sell 184.24K shares
84% Buy Activity
Negligible or No Correlation
Sell Signal Low Confidence
Jun 05, 2026

Analysis Breakdown:

  • Confidence increased due to high data reliability score of 100.

Historical Insider Trades

Date Type Person Role Amount
Nov 10, 2025
Sell
Class A Common Stock
S-Sale
Rhoads Ann D
Director
Director 2 000
Value: $170.0K
Nov 07, 2025
Sell
Class A Common Stock
S-Sale
Rhoads Ann D
Director
Director 8 000
Value: $648.0K
Sep 15, 2025
Sell
Class A Common Stock
S-Sale
Rhoads Ann D
Director
Director 10 000
Value: $584.6K
Sep 15, 2025
Sell
Class A Common Stock
S-Sale
Rhoads Ann D
Director
Director 10 000
Value: $584.6K
Jul 18, 2025
Buy
Stock Option (Right to Buy Class A Common Stock)
A-Award
Pfeil Keith W
President, CEO
CEO / President 40 000
Value: $2.25M
Jul 18, 2025
Buy
Stock Option (Right to Buy Class A Common Stock)
A-Award
Kline Kyle
Senior Vice President, CFO
CEO / President 20 909
Value: $1.18M
Jul 18, 2025
Buy
Stock Option (Right to Buy Class A Common Stock)
Kline Kyle
Senior Vice President, CFO
CEO / President 5 000
Value: $322.2K
Jul 18, 2025
Buy
Stock Option (Right to Buy Class A Common Stock)
Kline Kyle
Senior Vice President, CFO
CEO / President 5 000
Value: $400.9K
Jul 18, 2025
Buy
Stock Option (Right to Buy Class A Common Stock)
Kline Kyle
Senior Vice President, CFO
CEO / President 5 000
Value: $318.4K
Jul 18, 2025
Buy
Stock Option (Right to Buy Class A Common Stock)
Kline Kyle
Senior Vice President, CFO
CEO / President 5 000
Value: $265.7K
Jul 18, 2025
Buy
Stock Option (Right to Buy Class A Common Stock)
Kline Kyle
Senior Vice President, CFO
CEO / President 15 000
Value: $846.5K
Jul 18, 2025
Buy
Stock Option (Right to Buy Class A Common Stock)
Kline Kyle
Senior Vice President, CFO
CEO / President 7 500
Value: $389.0K
Jul 18, 2025
Buy
Stock Option (Right to Buy Class A Common Stock)
Kline Kyle
Senior Vice President, CFO
CEO / President 9 091
Value: $846.6K
Jul 18, 2025
Buy
Stock Option (Right to Buy Class A Common Stock)
Kline Kyle
Senior Vice President, CFO
CEO / President 9 091
Value: $846.6K
Jul 18, 2025
Buy
Stock Option (Right to Buy Class A Common Stock)
Kline Kyle
Senior Vice President, CFO
CEO / President 7 500
Value: $389.0K
Jul 18, 2025
Buy
Stock Option (Right to Buy Class A Common Stock)
Kline Kyle
Senior Vice President, CFO
CEO / President 15 000
Value: $846.5K
Jul 18, 2025
Buy
Stock Option (Right to Buy Class A Common Stock)
Kline Kyle
Senior Vice President, CFO
CEO / President 5 000
Value: $265.7K
Jul 18, 2025
Buy
Stock Option (Right to Buy Class A Common Stock)
Kline Kyle
Senior Vice President, CFO
CEO / President 5 000
Value: $318.4K
Jul 18, 2025
Buy
Stock Option (Right to Buy Class A Common Stock)
Kline Kyle
Senior Vice President, CFO
CEO / President 5 000
Value: $400.9K
Jul 18, 2025
Buy
Stock Option (Right to Buy Class A Common Stock)
Kline Kyle
Senior Vice President, CFO
CEO / President 5 000
Value: $322.2K
Jul 18, 2025
Buy
Stock Option (Right to Buy Class A Common Stock)
A-Award
Kline Kyle
Senior Vice President, CFO
CEO / President 20 909
Value: $1.18M
Jul 18, 2025
Buy
Stock Option (Right to Buy Class A Common Stock)
A-Award
Pfeil Keith W
President, CEO
CEO / President 40 000
Value: $2.25M
Feb 28, 2025
Sell
Class A Common Stock
S-Sale
Rhoads Ann D
Director
Director 7 500
Value: $590.1K
Jan 23, 2025
Buy
Stock Option (Right to Buy Class A Common Stock)
A-Award
Davidar David D
Director
Director 15 000
Value: $1.39M
Jan 23, 2025
Buy
Stock Option (Right to Buy Class A Common Stock)
A-Award
Deford John A
Director
Director 15 000
Value: $1.39M

About Insider Power

Insider Power is a proprietary algorithm developed by StockInvest.us to evaluate the significance of insider transactions. The calculation considers the size, type, and timing of transactions, as well as the insider’s role within the company.

It is important to note that, in general, there is little to no correlation between insider transactions and short-term stock price movements. In one of our studies, only 0.22%* of stocks with insider activity showed a measurable correlation — and even then, it was unclear whether the effect was caused by insider actions or simply by the stock’s broader trend.

While our algorithms are designed to highlight potentially meaningful signals, these cannot be regarded as statistically significant on their own. Insider trading activity should therefore be seen as informative rather than as direct trading guidance. The Insider Power metric was created to present this information in a clearer and more accessible way, helping investors better understand the possible context of insider activity.

* October 6th, 2025 - Tested on 5562 stocks

Click to get the best stock tips daily for free!
ABOUT GLOBUS MEDICAL INC
Globus Medical
Globus Medical, Inc., a medical device company, develops and commercializes healthcare solutions for patients with musculoskeletal disorders in the United States and internationally. It offers spine products, such as traditional fusion implants comprising pedicle screw and rod systems, plating systems, intervertebral spacers, and corpectomy devices for treating degenerative, deformity, tumors, and trauma conditions; treatment options for motion p...
GOLDEN STAR
Ticker Change Signal Date
EAT
$140.46
4.95% Jun 05
TPR
$140.47
0.320% Jun 04
N
NVRI
$19.53
4.92% May 20
GLBE
$31.61
3.54% May 05
FIZZ
$34.11
8.80% May 01

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE